Qiagen (QGEN) Operating Expenses (2009 - 2025)

Qiagen (QGEN) has 17 years of Operating Expenses data on file, last reported at $225.8 million in Q4 2025.

• Quarterly Operating Expenses rose 5.43% year-over-year to $225.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $640.3 million (down 26.14% YoY) and the FY2025 annual result came in at $833.6 million, down 4.14% from the prior year.
• Operating Expenses rose to $225.8 million in Q4 2025 per QGEN's latest filing, from $202.1 million in the prior quarter.
• The five-year high for Operating Expenses was $263.2 million in Q2 2024, with the low at $193.3 million in Q1 2025.
• Average Operating Expenses over 5 years is $210.3 million, with a median of $207.9 million recorded in 2022.
• Year-over-year, Operating Expenses grew 27.32% in 2024 and retreated 19.31% in 2025.
• Qiagen's Operating Expenses stood at $200.7 million in 2021, then rose by 6.11% to $213.0 million in 2022, then decreased by 3.51% to $205.5 million in 2023, then grew by 4.24% to $214.2 million in 2024, then rose by 5.43% to $225.8 million in 2025.
• Business Quant data shows QGEN's Operating Expenses at $225.8 million in Q4 2025, $202.1 million in Q3 2025, and $212.4 million in Q2 2025.